STUDIES ON THE DISTRIBUTION OF C-14 SULPIRIDE AND ITS METABOLITES IN THE RAT AND GUINEA-PIG

被引:7
作者
DROSS, K [1 ]
HOPF, A [1 ]
机构
[1] UNIV DUSSELDORF,INST HIRNFORSCH,D-4000 DUSSELDORF 1,FED REP GER
来源
PHARMAKOPSYCHIATRIE NEURO-PSYCHOPHARMAKOLOGIE | 1979年 / 12卷 / 06期
关键词
D O I
10.1055/s-0028-1094641
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
After ip. injection of 14C-labelled sulpiride in rats, about one third is metabolized while the other two thirds are excreted unchanged in feces and urine. The highest level of its metabolites was found in the liver (about 65% of total radioactivity). In the brain, 90% of the radioactivity consisted of unchanged sulpiride, which seems to be responsible for the central effects of the drug. The highest concentrations within the brain were found in the median eminence, circumventricular organs, plexus, and pineal body.
引用
收藏
页码:438 / 444
页数:7
相关论文
共 11 条
[1]   DISTRIBUTION AND FATE OF C14-AMITRIPTYLINE IN MICE AND RATS [J].
CASSANO, GB ;
SJOSTRAND, SE ;
HANSSON, E .
PSYCHOPHARMACOLOGIA, 1965, 8 (01) :1-+
[2]  
CASSANO GB, 1966, INT J NEUROPSYCH, V2, P269
[3]   ANTAGONISM OF HYPERACTIVITY INDUCED BY DOPAMINE APPLIED INTRACEREBRALLY TO NUCLEUS ACCUMBENS SEPTI BY TYPICAL NEUROLEPTICS AND BY CLOZAPINE, SULPIRIDE AND THIORIDAZINE [J].
COSTALL, B ;
NAYLOR, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 35 (01) :161-168
[4]  
DROSS K, 1978, ARZNEIMITTEL-FORSCH, V28-1, P824
[5]   AUTORADIOGRAPHIC STUDIES ON DISTRIBUTION OF PSYCHOACTIVE DRUGS IN RAT BRAIN .4. C-14 THIORIDAZINE [J].
ECKERT, H ;
HOPF, A .
INTERNATIONAL PHARMACOPSYCHIATRY, 1970, 4 (1-2) :98-&
[6]  
GLASSON B, 1972, 9 C INT GASTR PAR, P89
[7]   DOPAMINE RECEPTOR BLOCKING ACTIVITY OF SULPIRIDE IN CENTRAL NERVOUS-SYSTEM [J].
HONDA, F ;
SATOH, Y ;
SHIMOMURA, K ;
SATOH, H ;
NOGUCHI, H ;
UCHIDA, SI ;
KATO, R .
JAPANESE JOURNAL OF PHARMACOLOGY, 1977, 27 (03) :397-411
[8]   AUTORADIOGRAPHIC STUDIES ON DISTRIBUTION OF PSYCHOACTIVE DRUGS IN RAT BRAIN .3. C-14-PSILOCIN [J].
HOPF, A ;
ECKERT, H .
PSYCHOPHARMACOLOGIA, 1969, 16 (03) :201-&
[9]  
HOPF A, 1969, PHARMACOPSYCHIATRY, V2, P1
[10]  
SJOSTRAND SE, 1965, ARCH INT PHARMACOD T, V156, P34